Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jin Yan
Age : 46
Country of residence : Unknown
Linked companies : Tianqi Lithium Corporation

Biography of Jin Yan 
Currently, Jin Yan holds the position of Chairman-Supervisory Board at Tianqi Lithium Industries, Inc. and Chairman-Supervisory Board for Tianqi Lithium HK Co., Ltd. (a subsidiary of Tianqi Lithium Industries, Inc.). In her past career Ms. Yan held the position of Secretary of Chengdu Tanyutou Investment Co., Ltd. Ms. Yan received an undergraduate degree from Southwest University for Nationalities.


Current positions of Jin Yan 
Jin Yan : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Jin Yan : Connections 


Latest news about Jin Yan 
05/17JX Luxventure Forms Special Committee to Explore Sale of Menswear Sector
CI
2021Altaris Capital Partners, LLC completed the acquisition of Generic Rx Pharmaceuticals business of Perrigo Company plc.
CI
2021Altaris Capital Partners, LLC reached a definitive agreement to acquire Generic Rx Pharmaceuticals business of Perrigo Company plc for approximately $1.6 billion.
CI
2020South Huiton Co., Ltd. Elects Jin Yan as Director
CI
2020KBS Fashion Group Limited Announces Board Changes
CI
2020Zhejiang Xinan Chemical Industrial Group Co., Ltd. Announces Executive Appointments
CI
2020Bringspring Science and Technology Co., Ltd. completed the acquisition of 70% stake in Shanghai Creating Information Technology Co Ltd. from a group of sellers.
CI
More news